Notice of compliance with conditions: a policy in limbo.
about
Regulating prescription drugs for patient safety: does Bill C-17 go far enough?Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy.Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis.Progressive licensing of drugs: music or noise?Publication of confirmatory studies required by Health Canada for drugs approved under a Notice of Compliance with conditions: a cohort study.Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study.
P2860
Notice of compliance with conditions: a policy in limbo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Notice of compliance with conditions: a policy in limbo.
@en
type
label
Notice of compliance with conditions: a policy in limbo.
@en
prefLabel
Notice of compliance with conditions: a policy in limbo.
@en
P1433
P1476
Notice of compliance with conditions: a policy in limbo.
@en
P2093
Joel Lexchin
P304
P577
2007-05-01T00:00:00Z